Repligen Historical Financial Ratios

RGEN Stock

USD 167.53 1.87 1.10%

Repligen is promptly reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 33.32, Free Cash Flow Yield of 0.0071, Invested Capital of 0.0 or Operating Cash Flow Per Share of 1.93 will help investors to properly organize and evaluate Repligen financial condition quickly.

Quick Ratio Current Ratio

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

About Repligen Financial Ratios Analysis

RepligenFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Repligen investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Repligen financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Repligen history.

Repligen Financial Ratios Chart

At this time, Repligen's Net Income Per Share is very stable compared to the past year. As of the 31st of January 2025, Payables Turnover is likely to grow to 15.63, while Price To Sales Ratio is likely to drop 10.05.

Price To Sales Ratio Days Sales Outstanding Average Payables Ev To Sales

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Repligen stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Repligen sales, a figure that is much harder to manipulate than other Repligen multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most ratios from Repligen's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Repligen current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.At this time, Repligen's Net Income Per Share is very stable compared to the past year. As of the 31st of January 2025, Payables Turnover is likely to grow to 15.63, while Price To Sales Ratio is likely to drop 10.05.

	2022	2023	2024	2025 (projected)
Payables Turnover	12.55	16.54	14.88	15.63
Days Of Inventory On Hand	251.49	228.25	205.43	133.19

Payables Turnover Days Of Inventory On Hand

Repligen fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.33	0.01	0.62	-0.46	0.44	0.47	0.27	0.33	1.0	0.36	-0.13	-0.17	0.36	0.47	-0.16	0.53	0.3	0.75	0.75	-0.46	0.47	0.66	0.14	0.15	0.33
Ptb Ratio	0.33		-0.01	0.27	0.0	0.18	0.18	0.08	1.0	0.31	0.25	0.03	-0.11	0.01	0.04	-0.02	0.19	0.07	0.34	0.11	-0.14	0.07	0.04	-0.04	0.37	0.96
Days Sales Outstanding	0.01	-0.01		-0.01	0.61	0.03	0.09	-0.38	-0.01	0.05	0.24	0.54	-0.43	0.09	0.42	0.01	0.05	-0.61	-0.02	0.15	-0.03	0.04	0.03	-0.11	-0.21	0.05
Book Value Per Share	0.62	0.27	-0.01		-0.21	0.88	0.39	0.29	0.27	0.65	0.76	0.03	-0.32	0.6	0.5	0.46	0.46	0.41	0.95	0.52	-0.42	0.53	0.54	-0.42	0.43	0.37
Free Cash Flow Yield	-0.46	0.0	0.61	-0.21		0.0	0.11	-0.28	0.0	-0.43	0.28	0.84	-0.58	0.01	0.23	-0.03	-0.02	-0.64	-0.34	-0.19	0.56	-0.06	-0.27	0.01	0.0	0.16
Operating Cash Flow Per Share	0.44	0.18	0.03	0.88	0.0		0.56	0.48	0.18	0.48	0.8	0.3	-0.54	0.8	0.68	0.34	0.59	0.43	0.81	0.4	-0.22	0.72	0.51	-0.3	0.39	0.32
Average Payables	0.47	0.18	0.09	0.39	0.11	0.56		0.11	0.18	0.5	0.64	0.61	-0.85	0.42	0.83	-0.29	0.97	-0.12	0.51	0.73	-0.1	0.79	0.62	0.31	0.33	0.26
Capex To Depreciation	0.27	0.08	-0.38	0.29	-0.28	0.48	0.11		0.08	0.27	-0.02	-0.14	0.06	0.71	0.24	-0.04	0.14	0.81	0.21	0.0	0.04	0.52	0.36	0.0	-0.18	0.14
Pb Ratio	0.33	1.0	-0.01	0.27	0.0	0.18	0.18	0.08		0.31	0.25	0.03	-0.11	0.01	0.04	-0.02	0.19	0.07	0.34	0.11	-0.14	0.07	0.04	-0.04	0.37	0.96
Ev To Sales	1.0	0.31	0.05	0.65	-0.43	0.48	0.5	0.27	0.31		0.4	-0.08	-0.22	0.4	0.52	-0.14	0.57	0.28	0.77	0.77	-0.46	0.51	0.69	0.12	0.15	0.32
Free Cash Flow Per Share	0.36	0.25	0.24	0.76	0.28	0.8	0.64	-0.02	0.25	0.4		0.52	-0.72	0.37	0.62	0.39	0.64	-0.05	0.73	0.44	-0.11	0.46	0.28	-0.31	0.7	0.39
Roic	-0.13	0.03	0.54	0.03	0.84	0.3	0.61	-0.14	0.03	-0.08	0.52		-0.92	0.29	0.66	-0.2	0.51	-0.58	-0.01	0.28	0.39	0.42	0.18	0.19	0.07	0.2
Inventory Turnover	-0.17	-0.11	-0.43	-0.32	-0.58	-0.54	-0.85	0.06	-0.11	-0.22	-0.72	-0.92		-0.42	-0.83	0.15	-0.78	0.4	-0.33	-0.55	-0.14	-0.65	-0.43	-0.16	-0.26	-0.27
Net Income Per Share	0.36	0.01	0.09	0.6	0.01	0.8	0.42	0.71	0.01	0.4	0.37	0.29	-0.42		0.7	-0.02	0.44	0.47	0.49	0.35	-0.11	0.78	0.62	-0.03	-0.21	0.15
Days Of Inventory On Hand	0.47	0.04	0.42	0.5	0.23	0.68	0.83	0.24	0.04	0.52	0.62	0.66	-0.83	0.7		-0.16	0.82	-0.11	0.51	0.67	-0.04	0.82	0.67	0.16	0.03	0.18
Payables Turnover	-0.16	-0.02	0.01	0.46	-0.03	0.34	-0.29	-0.04	-0.02	-0.14	0.39	-0.2	0.15	-0.02	-0.16		-0.2	0.24	0.37	-0.21	-0.19	-0.16	-0.2	-0.95	0.4	0.01
Average Inventory	0.53	0.19	0.05	0.46	-0.02	0.59	0.97	0.14	0.19	0.57	0.64	0.51	-0.78	0.44	0.82	-0.2		-0.05	0.58	0.78	-0.15	0.8	0.67	0.24	0.33	0.25
Capex To Revenue	0.3	0.07	-0.61	0.41	-0.64	0.43	-0.12	0.81	0.07	0.28	-0.05	-0.58	0.4	0.47	-0.11	0.24	-0.05		0.38	-0.1	-0.3	0.27	0.2	-0.26	0.06	0.05
Cash Per Share	0.75	0.34	-0.02	0.95	-0.34	0.81	0.51	0.21	0.34	0.77	0.73	-0.01	-0.33	0.49	0.51	0.37	0.58	0.38		0.65	-0.57	0.57	0.6	-0.35	0.48	0.39
Pocfratio	0.75	0.11	0.15	0.52	-0.19	0.4	0.73	0.0	0.11	0.77	0.44	0.28	-0.55	0.35	0.67	-0.21	0.78	-0.1	0.65		-0.45	0.7	0.89	0.17	0.06	0.16
Interest Coverage	-0.46	-0.14	-0.03	-0.42	0.56	-0.22	-0.1	0.04	-0.14	-0.46	-0.11	0.39	-0.14	-0.11	-0.04	-0.19	-0.15	-0.3	-0.57	-0.45		-0.29	-0.45	0.35	-0.11	-0.02
Capex To Operating Cash Flow	0.47	0.07	0.04	0.53	-0.06	0.72	0.79	0.52	0.07	0.51	0.46	0.42	-0.65	0.78	0.82	-0.16	0.8	0.27	0.57	0.7	-0.29		0.86	0.09	0.02	0.18
Pfcf Ratio	0.66	0.04	0.03	0.54	-0.27	0.51	0.62	0.36	0.04	0.69	0.28	0.18	-0.43	0.62	0.67	-0.2	0.67	0.2	0.6	0.89	-0.45	0.86		0.12	-0.17	0.1
Days Payables Outstanding	0.14	-0.04	-0.11	-0.42	0.01	-0.3	0.31	0.0	-0.04	0.12	-0.31	0.19	-0.16	-0.03	0.16	-0.95	0.24	-0.26	-0.35	0.17	0.35	0.09	0.12		-0.29	-0.05
Income Quality	0.15	0.37	-0.21	0.43	0.0	0.39	0.33	-0.18	0.37	0.15	0.7	0.07	-0.26	-0.21	0.03	0.4	0.33	0.06	0.48	0.06	-0.11	0.02	-0.17	-0.29		0.38
Roe	0.33	0.96	0.05	0.37	0.16	0.32	0.26	0.14	0.96	0.32	0.39	0.2	-0.27	0.15	0.18	0.01	0.25	0.05	0.39	0.16	-0.02	0.18	0.1	-0.05	0.38

Click cells to compare fundamentals

Repligen Account Relationship Matchups

Repligen fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	27.5	21.73	11.71	15.84	14.26	10.05
Ptb Ratio	153.13	8.33	23.64	5.08	4.57	4.35
Days Sales Outstanding	71.14	63.92	52.94	71.67	64.5	42.05
Book Value Per Share	29.1	31.81	34.45	35.26	31.74	33.32
Free Cash Flow Yield	0.003603	0.003277	0.004125	0.007479	0.006731	0.007068
Operating Cash Flow Per Share	1.19	2.16	3.1	2.04	1.84	1.93
Stock Based Compensation To Revenue	0.0464	0.041	0.0341	0.0404	0.0465	0.0442
Capex To Depreciation	1.11	0.97	1.85	2.62	0.66	0.63
Pb Ratio	153.13	8.33	23.64	5.08	4.57	4.35
Ev To Sales	26.29	21.37	11.59	15.78	14.2	8.97
Free Cash Flow Per Share	0.69	0.87	0.7	1.34	1.21	1.27
Roic	0.0235	0.0496	0.047	0.0109	0.009831	0.0103
Inventory Turnover	1.65	1.51	1.45	1.6	1.84	1.75
Net Income Per Share	1.14	2.33	3.35	0.64	0.57	0.6
Days Of Inventory On Hand	221.43	241.12	251.49	228.25	205.43	133.19
Payables Turnover	9.28	7.71	12.55	16.54	14.88	15.63
Research And Ddevelopement To Revenue	0.0551	0.0511	0.0548	0.0676	0.0777	0.0738
Capex To Revenue	0.0719	0.11	0.17	0.0617	0.0709	0.097
Cash Per Share	13.65	10.98	11.25	13.48	12.14	12.74
Pocfratio	160.81	122.42	54.57	87.94	79.15	83.11
Interest Coverage	3.51	10.5	114.98	4.76	5.47	5.2
Capex To Operating Cash Flow	0.43	0.34	0.42	0.6	0.77	0.32
Pfcf Ratio	277.58	305.2	242.4	133.7	120.33	126.35
Days Payables Outstanding	39.34	47.31	29.08	22.07	19.86	20.86
Income Quality	3.14	1.05	0.93	2.74	3.15	3.31
Roe	0.91	0.0733	0.47	0.0181	0.0163	0.0171
Ev To Operating Cash Flow	153.76	120.42	53.98	87.6	78.84	82.78
Pe Ratio	168.06	113.57	50.49	281.45	253.3	265.97
Return On Tangible Assets	0.0298	0.0601	0.11	0.0247	0.0222	0.0233
Ev To Free Cash Flow	265.4	300.22	239.81	133.18	119.86	125.85
Earnings Yield	0.00595	0.008805	0.0198	0.003553	0.003198	0.003358
Intangibles To Total Assets	3.31	0.49	0.48	0.51	0.56	0.54
Net Debt To E B I T D A	(4.35)	(1.12)	(0.41)	(0.31)	(0.28)	(0.26)
Current Ratio	2.83	2.48	2.47	6.74	7.75	8.99
Tangible Book Value Per Share	11.87	10.04	12.65	10.36	11.91	12.51
Receivables Turnover	6.19	5.13	5.71	6.9	5.86	9.67
Graham Number	5.67	40.85	23.25	22.55	20.29	21.31

Pair Trading with Repligen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Repligen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will appreciate offsetting losses from the drop in the long position's value.

Moving against Repligen Stock

0.76	DYN	Dyne Therapeutics	Pair Corr
0.72	KZR	Kezar Life Sciences	Pair Corr
0.67	HCM	HUTCHMED DRC	Pair Corr
0.59	EWTX	Edgewise Therapeutics	Pair Corr
0.5	JNJ	Johnson Johnson	Pair Corr

The ability to find closely correlated positions to Repligen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Repligen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Repligen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Repligen to buy it.

The correlation of Repligen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Repligen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Repligen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Repligen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:

How To Invest In Repligen

Details

Is Repligen Stock a good investment?

Details

What is Repligen's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.

You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.83)

Earnings Share

(0.03)

Revenue Per Share

11.452

Quarterly Revenue Growth

0.097

Return On Assets

0.002

The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Repligen Historical Financial Ratios

About Repligen Financial Ratios Analysis

Repligen Financial Ratios Chart

Price To Sales Ratio

Average Payables

Ev To Sales

Repligen fundamentals Correlations

Repligen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Repligen fundamentals Accounts

Pair Trading with Repligen

Moving against Repligen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Average Inventory	+ 0.97	Average Payables
Roe	+ 0.96	Ptb Ratio
Roe	+ 0.96	Pb Ratio
Cash Per Share	+ 0.95	Book Value Per Share

Days Payables Outstanding	- 0.95	Payables Turnover
Inventory Turnover	- 0.92	Roic
Inventory Turnover	- 0.85	Average Payables
Days Of Inventory On Hand	- 0.83	Inventory Turnover
Average Inventory	- 0.78	Inventory Turnover
Inventory Turnover	- 0.72	Free Cash Flow Per Share